mRNA Vaccines: Risks, Readiness & Reality

Speakers: Dr. Chris Martenson, Dr. Joseph Varon, Dr. Paul Marik, Dr. Kirk Milhoan, Dr. Ryan Cole

Over the last several years, the Independent Medical Alliance (formerly FLCCC) has dedicated extensive resources to investigating the safety and effectiveness of COVID-19 mRNA injections. Our frontline doctors, along with countless others worldwide, noticed adverse reactions as soon as these products were rolled out in early 2021. Those observations have since snowballed into an undeniable safety signal—one that makes the COVID-19 mRNA “vaccines” the most dangerous on record. In fact, they account for more adverse events and deaths than all other vaccines combined, according to the CDC’s own Vaccine Adverse Event Reporting System (VAERS), visualized at OpenVAERS.

Recognizing the urgency, we joined the global research community, rigorously analyzing the mounting scientific evidence that points to the overwhelming harm caused by these vaccines. Our own affiliated doctors and researchers contributed to this growing body of knowledge, further validating the alarming volume of adverse events. This experience was a catalyst for the launch of our very own Journal of Independent Medicine, a platform dedicated to transparent, independent scientific inquiry.

We’ve also hosted numerous webinars with renowned experts across various medical fields—including many IMA Senior Fellows—who have highlighted the increased public health risks associated with mRNA COVID-19 vaccines. These include:

Children’s Heart Health Post COVID
Blood Clots from COVID “Vaccines”
COVID Vaccine Autopsy Reports: Shocking Impact Revealed
DNA Contamination in COVID-19 Vaccines
Excess Cancer Deaths in Young Adults Post-COVID

With this overwhelming body of evidence, combined with growing questions about vaccine effectiveness, one might wonder why these products remain on the market. The good news is that public awareness is rising, as recent data shows fewer than 20% of people are continuing to get boosted. The bad news? These injections are still widely available, despite mounting calls from medical experts for the FDA to revoke their Emergency Use Authorization.

As IMA Senior Fellow in Toxicology, Dr. Chris Martenson, warns:

“We’re hearing calls [for mRNA vaccines] because of this bird flu. We know that Moderna got this giant grant to create more of these vaccines… and it looks like they are going to rush through again… I think we’ve maybe learned some lessons that rushing wasn’t so hot last time.”

This isn’t just about COVID-19 anymore. The implications of mRNA technology extend to bird flu, RSV, cancer treatments, and beyond. In the interest of public health and the safety of future generations, this is something we cannot let go.

In this webinar, our experts gather once again to unpack the complex risks associated with the mRNA platform. Whether you’re concerned about COVID-19, future pandemics, or other proposed medical applications of mRNA, this is a must-watch. Press play on the video above and prepare to gain a deeper understanding of what’s at stake.

👉 Read more: IMA President Dr. Joseph Varon on “The Risks of Rushing Bird Flu mRNA Shots”

Meet the Experts: Trusted Voices in mRNA Vaccine Safety

Dr. Chris Martenson – Senior Fellow in Toxicology, IMA

Dr. Chris Martenson is a renowned expert in public health and economic analysis, holding a PhD in Pathology from Duke University. As the host of the Peak Prosperity podcast, he has become a trusted voice in navigating complex health crises with clarity and integrity. His expertise in toxicology provides critical insights into the safety and long-term impacts of mRNA technology.

Dr. Ryan Cole – Senior Fellow of Pathology, IMA

A board-certified anatomic and clinical pathologist, Dr. Ryan Cole is the founder of Cole Diagnostics, one of the largest independent medical labs in Idaho, processing over 40,000 blood and biopsy samples annually. With over 20 years of experience in dermatopathology and molecular diagnostics, Dr. Cole has been a leading voice on vaccine safety, leveraging his extensive background to scrutinize the mRNA platform’s risks.

Dr. Kirk Milhoan – Senior Fellow in Pediatric Cardiology, IMA

Specializing in pediatric cardiology and cardiovascular toxicity, Dr. Kirk Milhoan is a trusted authority on vaccine-induced heart conditions. Alongside his wife and fellow IMA Senior Fellow, Dr. Kimberly Milhoan, he co-founded “For Hearts and Souls,” a global medical mission providing pediatric cardiac care. A former USAF Medical Officer with extensive experience in infectious disease response, Dr. Milhoan brings a unique perspective to the cardiovascular risks posed by mRNA vaccines, particularly for children and young adults.

What’s Different Between an mRNA Vaccine and a Typical Vaccine?

It’s important to understand the difference between a typical vaccine and the mRNA vaccines. Dr. Ryan Cole breaks this down clearly:

Traditional Vaccines: Use a small part of a pathogen (like a protein) to trigger an immune response. This protein is recognized as foreign, prompting the body to create antibodies without causing disease.
mRNA “Vaccines”: Instead of delivering a protein, they deliver genetic instructions (mRNA) wrapped in lipid nanoparticles. These instructions tell your own cells to manufacture the foreign protein. This means your body’s own cells become the factory for the pathogen’s protein, displaying it on their surface.

Why Is This a Problem When it Comes to mRNA Vaccines?

Foreign Protein Production: Your cells aren’t meant to make foreign proteins. Doing so can confuse the immune system, potentially leading to autoimmunity or misdirected immune attacks.
Unknown Duration: The synthetic mRNA is designed to be more stable than natural mRNA, leading to prolonged protein production. As Dr. Cole points out, “We don’t know when the off switch is, if there is an off switch.”
Distribution and Targeting Issues: Unlike traditional vaccines that stay at the injection site, the lipid nanoparticles distribute the mRNA throughout the body. This means cells all over your body could start making the foreign protein, including heart cells, brain cells, and reproductive organs.

This is fundamentally different from how traditional vaccines work, introducing new risks that we’re just beginning to uncover. When our cells are programmed to create “foreign proteins”—like the spike protein from the COVID-19 vaccines—the implications for our immune system are profound.

Let’s take a closer look at one of the most concerning risks: what happens when our own cells become factories for these foreign, toxic proteins.

When Your Cells Become Factories for Foreign Proteins—What’s the Risk?

The idea that we’ve turned our own cells into factories for foreign proteins is downright unsettling. Dr. Milhoan puts it bluntly:

“It can go wrong in two ways. The first is that your body starts ignoring things that are bad for it. And the other way is it can start attacking itself if it’s been primed to do so.”

Why is This a Problem with mRNA Vaccines?

Foreign and Toxic Proteins: The mRNA vaccines instruct our cells to produce the spike protein from SARS-CoV-2, which is both foreign and toxic. As Dr. Milhoan highlights:

“We’re asking our body to make something that is toxic to itself.”

Cardiotoxic and Pro-inflammatory Effects: This spike protein is known to be cardiotoxic and pro-inflammatory, directly linking it to conditions like myocarditis and pericarditis.
Autoimmunity Risk: Since our own cells are creating the foreign protein, the immune system can become confused, leading to potential autoimmune responses where the body attacks itself.

But It Gets Worse…

Because the mRNA is modified with pseudo-uridine for stability, it stays active in the body far longer than natural mRNA. This means:

Prolonged Exposure: The toxic protein can be produced for an extended period, leading to chronic inflammation and immune confusion.
No Off Switch: There’s no clear mechanism to stop the body from continuing to produce this harmful protein.

This combination of prolonged production, toxic protein, and immune confusion creates a perfect storm for autoimmune issues and other health complications.

The “m” in mRNA Stands for “Modified” – Is That a Problem?

Our bodies constantly produce natural proteins essential for our health. But the mRNA in these vaccines isn’t just any messenger—it’s synthetically modified. As Dr. Ryan Cole explains, “In a normal vaccine, proteins get broken down, and they’re gone.” But these modified versions don’t follow that rule.

This synthetic mRNA is designed to last longer in the body, potentially instructing cells to produce toxic spike proteins indefinitely. The result? Prolonged exposure to a foreign, inflammatory protein with no clear off-switch.

What is a Lipid Nanoparticle (LNP), and Why Should You Care?

Lipid nanoparticles (LNPs) are tiny fat bubbles designed to deliver mRNA into cells. According to Wikipedia, they are “very small spherical particles composed of lipids” and are used in novel drug delivery systems. In mRNA vaccines, LNPs act as vehicles to carry the genetic code into our cells.

But here’s the catch: unlike traditional vaccines, which mostly stay localized at the injection site, LNPs travel throughout the body. As Dr. Cole explains:

“It went to the bone marrow, it went to the liver, it went to the brain, it concentrates in the ovaries… mRNA is fragile, so they protect it in this little fat bubble. But no matter what mRNA you put in there, it’s still gonna go everywhere.”

This widespread distribution raises serious questions about safety. The inability to target these particles to specific cells means they can deposit in sensitive areas, potentially causing unintended damage.

Why Does This Matter?

Because the mRNA in the vaccine isn’t limited to the injection site. It can be taken up by virtually any cell, turning it into a factory for foreign proteins. This untargeted distribution is why experts like Dr. Cole argue that mRNA technology isn’t ready for cancer treatments or other precision medicine applications.

If we can’t control where these particles go, how can we control what they do once they get there?

Cross-Contamination: A Feature, Not a Bug

One of the most troubling aspects of the mRNA platform is its inherent susceptibility to cross-contamination. This isn’t just a minor issue—it’s a fundamental flaw that affects every step of the manufacturing process.

Dr. Milhoan explained that when you produce mRNA at scale, ensuring a clean product becomes nearly impossible:

“In my PhD work, trying to flush out all the contaminants is incredibly laborious… When you’re trying to do large-scale millions and billions of doses… it’s not easy to get these things clean.”

This is especially concerning because these contaminants include fragments of DNA, SV40 promoters, and even microscopic debris like rubber and metal particles. Unlike traditional pharmaceuticals, where impurities are minimized and heavily regulated, the mRNA platform introduces these contaminants directly into the bloodstream, encapsulated in lipid nanoparticles (LNPs) that help them evade normal immune defenses.

Dr. Cole highlighted how this contamination risk is amplified by the very design of the LNPs:

“This is protected DNA within the same package that’s designed to fuse and go into your cells… contaminated at hundreds of times the allowable amount is completely out of the ballpark in terms of regulatory allowances and the risks they carry.”

This means the contaminants are not just present—they are delivered with high efficiency directly into your cells, where they can integrate into your DNA or interfere with normal cellular processes.

This isn’t a rare manufacturing glitch. It’s a design feature of the mRNA platform itself. And until this platform undergoes significant reform, cross-contamination will remain an inherent risk.

Incomplete Testing and Regulatory Oversight: A Recipe for Risk

The COVID-19 vaccines were rushed to market, completed from inception to distribution in under a year—unprecedented for any vaccine. Under normal circumstances, vaccines undergo extensive long-term safety studies, but these were bypassed under Emergency Use Authorization. As Dr. Cole cautions, “We won’t know the full impact for 10 to 20 years.”

The rapid rollout wasn’t just fast—it was sloppy. Basic safety protocols were ignored. For example, healthcare workers were not required to aspirate the needle to check if they were injecting directly into a blood vessel. Drive-thru vaccinations at football stadiums don’t exactly allow for careful oversight either.

Even more troubling, regulatory oversight was alarmingly lax. Internal documents obtained through FOIA requests revealed that key safety concerns were downplayed or ignored. With such incomplete testing and lack of transparency, it’s worth questioning whether informed consent was even possible.

Now, with signs of a bird flu mRNA vaccine being fast-tracked in a similar manner, are we poised to repeat the same mistakes?

Navigating Uncharted Territory with mRNA Technology

The rapid rollout of mRNA vaccines has left us with more questions than answers. The absence of long-term safety studies means we don’t fully understand the impact on autoimmune diseases, cancer, and reproductive health. This lack of data also challenges the notion of informed consent—how can people make educated health decisions without a complete picture of the risks?

The rushed approval process and incomplete safety data have shaken public trust. Moving forward, rigorous, independent research is crucial. This is not just about mRNA vaccines. It’s about ensuring transparency, accountability, and safety in all medical innovations. If we can’t get this right, what else could go wrong?

Why Honest Medicine™ Matters

This is why Honest Medicine is more important than ever. The Independent Medical Alliance (IMA) is committed to restoring trust by providing transparent, evidence-based information. During the webinar, IMA President and Journal Editor-in-Chief Dr. Joseph Varon and Chief Scientific Officer Dr. Paul Marik discussed the significance of IMA’s newly launched Journal of Independent Medicine, a platform dedicated to unbiased scientific inquiry and open dialogue.

The journal serves as a critical resource for healthcare professionals, researchers, and the public alike, offering peer-reviewed studies free from corporate influence. This initiative is a cornerstone in IMA’s mission to advocate for truth in medicine and empower people with knowledge.

Learn more about the Journal of Independent Medicine and why transparent, independent research is the foundation of health sovereignty. This journal is free to access and 100% donor supported.